JAK2 and Increased total eosinophil count: Both the World Health Organization (WHO) and the International Consensus Classification (ICC) have updated the former category of “Myeloid/Lymphoid Neoplasms Associated with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, FGFR1, or PCM1::JAK2”.